- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 12, Issue 3, 2005
Current Medicinal Chemistry - Volume 12, Issue 3, 2005
Volume 12, Issue 3, 2005
-
-
Management of Bladder, Prostatic and Pelvic Floor Disorders with Botulinum Neurotoxin
Authors: G. Maria, F. Cadeddu, D. Brisinda, F. Brandara and G. BrisindaSince its introduction in the late 1970s for the treatment of strabismus and blepharospasm, botulinum toxin (BoNT) has been increasingly used in the interventional treatment of several other disorders characterized by excessive or inappropriate muscle contractions. The use of this pluripotential agent has extended to a plethora of conditions including: focal dystonia; spasticity; inappropriate contraction in most sphin Read More
-
-
-
Role of Nitrosative Stress and Peroxynitrite in the Pathogenesis of Diabetic Complications. Emerging New Therapeutical Strategies
Authors: Pal Pacher, Irina G. Obrosova, Jon G. Mabley and Csaba SzaboMacro- and microvascular disease are the most common causes of morbidity and mortality in patients with diabetes mellitus. Diabetic cardiovascular dysfunction represents a problem of great clinical importance underlying the development of various severe complications including retinopathy, nephropathy, neuropathy and increase the risk of stroke, hypertension and myocardial infarction. Hyperglycemic episodes, Read More
-
-
-
Novel Biological Agents for the Treatment of Hormone-Refractory Prostate Cancer (HRPC)
Authors: A. G. Papatsoris, M. V. Karamouzis and A. G. PapavassiliouHormone-refractory prostate cancer (HRPC) is an inevitable evolution of prostate carcinogenesis, through which the normal dependence on hormones for growth and survival is bypassed. Although advances in terms of symptoms palliation and quality of life improvement have been addressed with current treatment options, innovative approaches are needed to improve survival rates. A thorough understanding of H Read More
-
-
-
Chemotherapy of Breast Cancer in the Elderly
Authors: A. Rossi, G. Colantuoni, P. Maione, C. Ferrara, G. Airoma, M. L. Barzelloni, V. Castaldo and C. GridelliBreast cancer arises in about 48% of patients older than 65 years and more than 30% occurs in those over 70 years being the leading cause of cancer-related death in women older than 65. Elderly patients tolerate chemotherapy poorly compared to their younger counterpart because of progressive reduction of organ function and comorbidities related to age. For this reason, the elderly have been excluded from or under Read More
-
-
-
Structure and Regulation of the Drug-Metabolizing Enzymes Arylamine N-acetyltransferases
Authors: Jean-Marie Dupret and Fernando Rodrigues-LimaArylamine N-acetyltransferases (NAT) are xenobiotic-metabolizing enzymes responsible for Nacetylation of many arylamines. They are also important for O-acetylation of N-hydroxylated heterocyclic amines. These enzymes play thus an important role in the detoxification and activation of numerous therapeutic drugs and carcinogens. Two closely related polymorphic isoforms (NAT1 and NAT2) have been described in hu Read More
-
-
-
Recent Advances in Pretargeted Radioimmunotherapy
Authors: A. Gruaz-Guyon, O. Raguin and J. BarbetPretargeted delivery of radionuclides is based upon bispecific immunoconjugates that bind a target tumor antigen and a small molecule carrying the active payload. This strategy is supposed to combine the advantage of antibodies to track tumor cells in vivo and of small radiolabeled molecules that clear rapidly from normal organs and minimize toxicity. Many pretargeting approaches have been proposed, but only tho Read More
-
-
-
Matrix Metalloproteinase Inhibitors: A Review on Pharmacophore Mapping and (Q)Sars Results
Authors: C. A. Kontogiorgis, P. Papaioannou and D. J. Hadjipavlou-LitinaThe matrix metalloproteinases (MMPs) are a family of more than 20 enzymes that are intimately involved in tissue remodelling. These zinc-containing endopeptidases consist of several subsets of enzymes, including collagenase, stromelysins and gelatinases and are involved in the degradation of the extracellullar matrix (ECM) that forms the connective material between cells and around tissues. Disease processes a Read More
-
-
-
NF-κB in Human Disease: Current Inhibitors and Prospects for De Novo Structure Based Design of Inhibitors
Authors: V. Pande and M. J. RamosNuclear-Factor kappa B (NF-κB) is an inducible transcription factor of the Rel family, sequestered in the cytoplasm by the IkB family of proteins. NF-κB exists in several dimeric forms, but the p50 / p65 heterodimer is the predominant one. Activation of NF-κB by a range of physical, chemical, and biological stimuli leads to phosphorylation and proteasome dependent degradation of IkB, leading to the release of free NF-κB. This free Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
